Role of transporter-mediated efflux in the placental biodisposition of bupropion and its metabolite, OH-bupropion

Sarah J. Hemauer, Svetlana L. Patrikeeva, Xiao-Ming Wang, Doaa R. Abdelrahman, Gary Hankins, Mahmoud Ahmed, Tatiana Nanovskaya

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Cigarette smoking during pregnancy is a preventable risk factor associated with maternal and fetal complications. Bupropion is an antidepressant used successfully for smoking cessation in non-pregnant patients. Our goal is to determine whether it could benefit the pregnant patient seeking smoking cessation. The aim of this investigation was to determine the role of human placenta in the disposition of bupropion and its major hepatic metabolite, OH-bupropion. The expression of efflux transporters P-gp and BCRP was determined in placental brush border membrane (n=200) and revealed a positive correlation (p<0.05). Bupropion was transported by BCRP (Kt 3μM, Vmax 30pmol/mg protein/min) and P-gp (Kt 0.5μM, Vmax 6pmol/mg protein*min) in placental inside-out vesicles (IOVs). OH-bupropion crossed the dually-perfused human placental lobule without undergoing further metabolism, nor was it an efflux substrate of P-gp or BCRP. In conclusion, our data indicate that human placenta actively regulates the disposition of bupropion (via metabolism, active transport), but not its major hepatic metabolite, OH-bupropion.

Original languageEnglish (US)
Pages (from-to)1080-1086
Number of pages7
JournalBiochemical Pharmacology
Volume80
Issue number7
DOIs
StatePublished - Oct 2010

Fingerprint

Bupropion
Metabolites
Smoking Cessation
Metabolism
Placenta
Active Biological Transport
Liver
Brushes
Microvilli
hydroxide ion
Tobacco Products
Antidepressive Agents
Proteins
Smoking
Mothers
Membranes
Pregnancy
Substrates

Keywords

  • Breast cancer resistance protein
  • Bupropion
  • P-Glycoprotein
  • Placenta
  • Smoking

ASJC Scopus subject areas

  • Pharmacology
  • Biochemistry
  • Medicine(all)

Cite this

Role of transporter-mediated efflux in the placental biodisposition of bupropion and its metabolite, OH-bupropion. / Hemauer, Sarah J.; Patrikeeva, Svetlana L.; Wang, Xiao-Ming; Abdelrahman, Doaa R.; Hankins, Gary; Ahmed, Mahmoud; Nanovskaya, Tatiana.

In: Biochemical Pharmacology, Vol. 80, No. 7, 10.2010, p. 1080-1086.

Research output: Contribution to journalArticle

Hemauer, Sarah J. ; Patrikeeva, Svetlana L. ; Wang, Xiao-Ming ; Abdelrahman, Doaa R. ; Hankins, Gary ; Ahmed, Mahmoud ; Nanovskaya, Tatiana. / Role of transporter-mediated efflux in the placental biodisposition of bupropion and its metabolite, OH-bupropion. In: Biochemical Pharmacology. 2010 ; Vol. 80, No. 7. pp. 1080-1086.
@article{39025542b85e46acad9e365cbc01a1fa,
title = "Role of transporter-mediated efflux in the placental biodisposition of bupropion and its metabolite, OH-bupropion",
abstract = "Cigarette smoking during pregnancy is a preventable risk factor associated with maternal and fetal complications. Bupropion is an antidepressant used successfully for smoking cessation in non-pregnant patients. Our goal is to determine whether it could benefit the pregnant patient seeking smoking cessation. The aim of this investigation was to determine the role of human placenta in the disposition of bupropion and its major hepatic metabolite, OH-bupropion. The expression of efflux transporters P-gp and BCRP was determined in placental brush border membrane (n=200) and revealed a positive correlation (p<0.05). Bupropion was transported by BCRP (Kt 3μM, Vmax 30pmol/mg protein/min) and P-gp (Kt 0.5μM, Vmax 6pmol/mg protein*min) in placental inside-out vesicles (IOVs). OH-bupropion crossed the dually-perfused human placental lobule without undergoing further metabolism, nor was it an efflux substrate of P-gp or BCRP. In conclusion, our data indicate that human placenta actively regulates the disposition of bupropion (via metabolism, active transport), but not its major hepatic metabolite, OH-bupropion.",
keywords = "Breast cancer resistance protein, Bupropion, P-Glycoprotein, Placenta, Smoking",
author = "Hemauer, {Sarah J.} and Patrikeeva, {Svetlana L.} and Xiao-Ming Wang and Abdelrahman, {Doaa R.} and Gary Hankins and Mahmoud Ahmed and Tatiana Nanovskaya",
year = "2010",
month = "10",
doi = "10.1016/j.bcp.2010.06.025",
language = "English (US)",
volume = "80",
pages = "1080--1086",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Role of transporter-mediated efflux in the placental biodisposition of bupropion and its metabolite, OH-bupropion

AU - Hemauer, Sarah J.

AU - Patrikeeva, Svetlana L.

AU - Wang, Xiao-Ming

AU - Abdelrahman, Doaa R.

AU - Hankins, Gary

AU - Ahmed, Mahmoud

AU - Nanovskaya, Tatiana

PY - 2010/10

Y1 - 2010/10

N2 - Cigarette smoking during pregnancy is a preventable risk factor associated with maternal and fetal complications. Bupropion is an antidepressant used successfully for smoking cessation in non-pregnant patients. Our goal is to determine whether it could benefit the pregnant patient seeking smoking cessation. The aim of this investigation was to determine the role of human placenta in the disposition of bupropion and its major hepatic metabolite, OH-bupropion. The expression of efflux transporters P-gp and BCRP was determined in placental brush border membrane (n=200) and revealed a positive correlation (p<0.05). Bupropion was transported by BCRP (Kt 3μM, Vmax 30pmol/mg protein/min) and P-gp (Kt 0.5μM, Vmax 6pmol/mg protein*min) in placental inside-out vesicles (IOVs). OH-bupropion crossed the dually-perfused human placental lobule without undergoing further metabolism, nor was it an efflux substrate of P-gp or BCRP. In conclusion, our data indicate that human placenta actively regulates the disposition of bupropion (via metabolism, active transport), but not its major hepatic metabolite, OH-bupropion.

AB - Cigarette smoking during pregnancy is a preventable risk factor associated with maternal and fetal complications. Bupropion is an antidepressant used successfully for smoking cessation in non-pregnant patients. Our goal is to determine whether it could benefit the pregnant patient seeking smoking cessation. The aim of this investigation was to determine the role of human placenta in the disposition of bupropion and its major hepatic metabolite, OH-bupropion. The expression of efflux transporters P-gp and BCRP was determined in placental brush border membrane (n=200) and revealed a positive correlation (p<0.05). Bupropion was transported by BCRP (Kt 3μM, Vmax 30pmol/mg protein/min) and P-gp (Kt 0.5μM, Vmax 6pmol/mg protein*min) in placental inside-out vesicles (IOVs). OH-bupropion crossed the dually-perfused human placental lobule without undergoing further metabolism, nor was it an efflux substrate of P-gp or BCRP. In conclusion, our data indicate that human placenta actively regulates the disposition of bupropion (via metabolism, active transport), but not its major hepatic metabolite, OH-bupropion.

KW - Breast cancer resistance protein

KW - Bupropion

KW - P-Glycoprotein

KW - Placenta

KW - Smoking

UR - http://www.scopus.com/inward/record.url?scp=77955654070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955654070&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2010.06.025

DO - 10.1016/j.bcp.2010.06.025

M3 - Article

VL - 80

SP - 1080

EP - 1086

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 7

ER -